As of June 10, 2025, Guangzhou Jet Bio-Filtration Co Ltd (688026.SS) reports a Gross Margin of 40.47%.
Gross Margin indicates the portion of sales revenue remaining after covering production costs, highlighting operational efficiency.
Historical Trend of Guangzhou Jet Bio-Filtration Co Ltd's Gross Margin
Over recent years, Guangzhou Jet Bio-Filtration Co Ltd's Gross Margin has shown a moderate pattern. The table below summarizes the historical values:
| Date | Gross Margin |
|---|---|
| 2024-12-31 | 40.47% |
| 2023-12-31 | 29.35% |
| 2022-12-31 | 29.29% |
| 2021-12-31 | 40.60% |
| 2020-12-31 | 42.49% |
This slight upward trend highlights how Guangzhou Jet Bio-Filtration Co Ltd manages its operational efficiency and pricing power over time.
Comparing Guangzhou Jet Bio-Filtration Co Ltd's Gross Margin to Peers
To better understand Guangzhou Jet Bio-Filtration Co Ltd's position, it's useful to compare its Gross Margin against industry peers. Below are selected comparisons:
| Company | Gross Margin |
|---|---|
| Guangzhou Jet Bio-Filtration Co Ltd (688026.SS) | 40.47% |
| Sansure Biotech Inc (688289.SS) | 81.00% |
| Kangji Medical Holdings Ltd (9997.HK) | 79.08% |
| Autek China Inc (300595.SZ) | 73.24% |
| Shanghai MicroPort Endovascular MedTech Group Co Ltd (688016.SS) | 72.62% |
| Poly Medicure Ltd (POLYMED.NS) | 66.78% |
Compared to its competitors, Guangzhou Jet Bio-Filtration Co Ltd's Gross Margin is about average compared to peers, indicating industry-standard operational efficiency.